comprehensive -WSS

comprehensive

author：hotspot 2025-09-29 00:34:14 - browse：2

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： How Long Island became the ‘eugenics capital of the world’

WSS

Neuroscience startup Neumora files for IPO

Diversity in medical illustrations gets boost from Chidiebere Ibe

Do masks work? RCTs can't tell us

CDC advisory panel says seniors 'may' get RSV vaccine

Why drug prescriptions should include diagnoses

How to make AI work for medicine

hotspot

comprehensive

focus

What does generative AI mean for health care? We asked experts

Ask STAT: What do you want to know about ChatGPT in medicine?

State Dept. review finds Biden bears some blame for Afghanistan failures

Why more medical students aren't specializing in primary care

Dobbs anniversary: the lost opportunity of abortion as health care

The battle over the Brookhaven Landfill on Long Island

As demand for Covid shots wanes, Moderna seeks its next success

Radiation, mainstay of cancer treatment, begins a fade

Heart attack and stroke risk calculators need revising

The strategy behind pharma's lawsuits over drug pricing reform

hotspot

Colonoscopy at 40? Study finds a possible benefit

New guidelines on severe brain injury complicate already difficult decisions

#NeedHerScience: shining a light on gender disparities in medicine

Appeals court upholds limits to abortion pill

What would happen to your eyes if you looked at the solar eclipse?

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Wikipedia

leisure time

hotspot

leisure time